© 2024 Western New York Public Broadcasting Association

140 Lower Terrace
Buffalo, NY 14202

Mailing Address:
Horizons Plaza P.O. Box 1263
Buffalo, NY 14240-1263

Buffalo Toronto Public Media | Phone 716-845-7000
WBFO Newsroom | Phone: 716-845-7040
Your NPR Station
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Joanne Silberner

Joanne Silberner is a health policy correspondent for National Public Radio. She covers medicine, health reform, and changes in the health care marketplace.

Silberner has been with NPR since 1992. Prior to that she spent five years covering consumer health and medical research at U.S. News & World Report. In addition she has worked at Science News magazine, Science Digest, and has freelanced for various publications. She has been published in The Washington Post, Health, USA Today, American Health, Practical Horseman, Encyclopedia Britannica, and others.

She was a fellow for a year at the Harvard School of Public Health, and from 1997-1998, she had a Kaiser Family Foundation media fellowship. During that fellowship she chronicled the closing of a state mental hospital. Silberner also had a fellowship to study the survivors of the bombings of Hiroshima and Nagasaki.

Silberner has won awards for her work from the Society of Professional Journalists, the New York State Mental Health Association, the March of Dimes, Easter Seals, the American Heart Association, and others. Her work has also earned her a Unity Award and a Clarion Award.

A graduate of Johns Hopkins University, Silberner holds her B.A. in biology. She has a master's degree in journalism from Columbia University Graduate School of Journalism.

She currently resides in Washington, D.C.

  • U.S. officials say it is too early to say whether the swine flu threat is receding. When the outbreak was first detected, the U.S. government was prepared. Morning Edition goes behind the scenes to the strategy center at the Department of Health and Human Services that is coordinating the medical response.
  • As scientists investigate the new swine flu virus, they're asking some fundamental biological questions. Some of the unanswered questions are: How far will it spread and how much disease will it cause?
  • Richard Besser, acting director of the Centers for Disease Control and Prevention, says the goal of public health agencies in the U.S. is to minimize the impact of the new swine flu virus. Right now, he says, states with and without infections are receiving items from a national stockpile of things that can be used to fight the flu.
  • The World Health Organization has raised the worldwide pandemic alert level to Phase 4. President Obama has said the government is closely monitoring the new swine flu virus, and while it's cause for concern, it's not a cause for alarm.
  • President Obama named Margaret Hamburg as his choice to lead the Food and Drug Administration. Hamburg led New York City through a tuberculosis epidemic as health commissioner in the 1990s.
  • President Obama is expected to name former New York City Health Commissioner Margaret Hamburg to lead the troubled Food and Drug Administration.
  • Former New York City Health Commissioner Margaret "Peggy" Hamburg is expected to be President Barack Obama's nominee to head the Food and Drug Administration. Hamburg is currently with the Nuclear Threat Initiative in Washington.
  • The federal government has so far identified 600 people who've gotten sick from salmonella traced to peanuts. Scientists estimate there are 30 or more actual cases for every one that's reported. Nine deaths have been linked to the outbreak, and it's led to one of the biggest food recalls in recent years. A House subcommittee held a hearing Wednesday on the salmonella outbreak.
  • As cleanup continues on the giant sludge spill from a Tennessee coal plant, government officials are trying to figure out how much of a disaster it is. It could pose a hazard to people and the environment.
  • Advisers to the Food and Drug Administration have recommend that drugs Serevent and Foradil no longer be used for asthma. Top-selling Advair was not affected by the recommendation.